# ACR 2017 abstract

Build tables for Atul's 2017 ACR abstract.
Collects code chunks from `summarizePrevalence.Rmd` and `summarizeIncidence.Rmd`.

* Title
  * **Do TNF Inhibitors Reduce the Incidence of Cardiac, Pulmonary and Neurologic Comorbidities in Ankylosing Spondylitis? An Analysis of Three Large US Claims Databases.**
* Authors
  * Atul Deodhar, Kevin Winthrop, Benjamin Chan, Sarah Siegel, Jeffery Stark, Robert Suruki, Rhonda Bohn, Huifeng Yun, Lang Chen, Jeffery Curtis


## Prevalence


|outcomeCategory            |disease                                   |timeWindow                                       | MPCD TNF| MPCD DMARD| MPCD NSAID or no exposure| Marketscan TNF| Marketscan DMARD| Marketscan NSAID or no exposure| Medicare TNF| Medicare DMARD| Medicare NSAID or no exposure|
|:--------------------------|:-----------------------------------------|:------------------------------------------------|--------:|----------:|-------------------------:|--------------:|----------------:|-------------------------------:|------------:|--------------:|-----------------------------:|
|Cancer                     |Hematologic Cancer                        |12-month (6-month baseline to 6-month follow-up) |      0.3|        0.2|                       0.4|            0.2|              0.6|                             0.5|          0.8|            2.0|                           2.1|
|Cancer                     |Non Melanoma Skin Cancer                  |12-month (6-month baseline to 6-month follow-up) |      0.0|        0.0|                       0.0|            0.2|              0.1|                             0.2|          0.9|            0.9|                           1.5|
|Cancer                     |Solid Cancer                              |12-month (6-month baseline to 6-month follow-up) |      2.1|        1.5|                       3.5|            0.8|              2.9|                             2.5|          6.6|            9.0|                          12.1|
|Cardiac disease            |Aortic Insufficiency/Aortic Regurgitation |12-month (6-month baseline to 6-month follow-up) |      1.8|        1.0|                       1.5|            0.5|              0.6|                             0.7|          2.5|            3.4|                           4.5|
|Cardiac disease            |Conduction Block                          |12-month (6-month baseline to 6-month follow-up) |      0.2|        0.0|                       0.7|            0.5|              0.9|                             0.9|          2.2|            2.8|                           4.5|
|Cardiac disease            |Myocardial infarction                     |12-month (6-month baseline to 6-month follow-up) |      0.0|        0.0|                       0.0|            0.2|              0.1|                             0.6|          0.3|            0.6|                           1.0|
|Infection                  |Hospitalized infection                    |12-month (6-month baseline to 6-month follow-up) |      0.1|        0.0|                       0.2|            2.9|              3.5|                             5.6|          7.2|           11.2|                          15.4|
|Infection                  |Opportunistic infection                   |12-month (6-month baseline to 6-month follow-up) |      1.3|        1.0|                       0.8|            0.7|              0.8|                             0.5|          3.3|            3.1|                           2.1|
|Inflammatory bowel disease |Crohnâ€™s Disease                           |12-month (6-month baseline to 6-month follow-up) |      5.8|        3.7|                       3.1|            3.7|              2.7|                             1.9|          8.4|            6.4|                           4.0|
|Inflammatory bowel disease |Ulcerative Colitis                        |12-month (6-month baseline to 6-month follow-up) |      2.9|        2.5|                       1.6|            2.2|              1.5|                             1.1|          4.2|            3.8|                           2.3|
|Kidney disease             |Amyloidosis                               |12-month (6-month baseline to 6-month follow-up) |      0.0|        0.0|                       0.0|            0.0|              0.0|                             0.0|          0.1|            0.0|                           0.1|
|Kidney disease             |IgA nephropathy                           |12-month (6-month baseline to 6-month follow-up) |      0.3|        0.2|                       0.1|            0.1|              0.1|                             0.0|          0.2|            0.3|                           0.2|
|Kidney disease             |Nephrotic syndrome                        |12-month (6-month baseline to 6-month follow-up) |      0.0|        0.0|                       0.0|            0.0|              0.0|                             0.0|          0.2|            0.3|                           0.2|
|Lung disease               |Apical Pulmonary fibrosis                 |12-month (6-month baseline to 6-month follow-up) |      0.0|        0.0|                       0.0|            0.0|              0.0|                             0.0|          0.0|            0.1|                           0.0|
|Lung disease               |Interstitial lung disease                 |12-month (6-month baseline to 6-month follow-up) |      0.0|        0.0|                       0.0|            0.1|              0.0|                             0.1|          0.1|            0.3|                           0.1|
|Lung disease               |Restrictive lung disease                  |12-month (6-month baseline to 6-month follow-up) |      0.7|        0.4|                       1.2|            0.7|              0.8|                             1.0|          6.5|            9.4|                           9.7|
|Neurological Disease       |Cauda Equina syndrome                     |12-month (6-month baseline to 6-month follow-up) |      0.0|        0.0|                       0.1|            0.0|              0.1|                             0.0|          0.1|            0.0|                           0.2|
|Neurological Disease       |Spinal Cord compression                   |12-month (6-month baseline to 6-month follow-up) |      0.2|        0.0|                       0.3|            0.1|              0.2|                             0.2|          0.5|            0.7|                           1.2|
|PsO/PsA                    |Psoriasis                                 |12-month (6-month baseline to 6-month follow-up) |      4.1|        1.2|                       1.8|            0.8|              0.9|                             0.5|          5.0|            3.5|                           1.8|
|PsO/PsA                    |Psoriatic arthritis                       |12-month (6-month baseline to 6-month follow-up) |      6.4|        5.4|                       2.2|            2.2|              2.1|                             0.6|         11.0|            8.5|                           3.2|
|Uveitis                    |Uveitis                                   |12-month (6-month baseline to 6-month follow-up) |      7.2|        5.8|                       5.2|            1.9|              1.5|                             1.6|          8.0|            5.3|                           4.1|


## Incidence


|outcomeCategory            |disease                                   | MPCD TNF| MPCD NSAID or no exposure|MPCD p-value | Marketscan TNF| Marketscan NSAID or no exposure|Marketscan p-value | Medicare TNF| Medicare NSAID or no exposure|Medicare p-value |
|:--------------------------|:-----------------------------------------|--------:|-------------------------:|:------------|--------------:|-------------------------------:|:------------------|------------:|-----------------------------:|:----------------|
|Cancer                     |Hematologic Cancer                        |      0.2|                       0.4|NS           |            0.2|                             0.5|0.005              |          0.6|                           1.3|<0.001           |
|Cancer                     |Non Melanoma Skin Cancer                  |      0.0|                       0.0|NS           |            0.3|                             0.2|NS                 |          1.0|                           1.6|<0.001           |
|Cancer                     |Solid Cancer                              |      1.8|                       3.7|<0.001       |            0.9|                             2.7|<0.001             |          4.0|                           8.0|<0.001           |
|Cardiac disease            |Aortic Insufficiency/Aortic Regurgitation |      1.3|                       1.6|NS           |            0.6|                             0.8|NS                 |          1.9|                           3.4|<0.001           |
|Cardiac disease            |Conduction Block                          |      0.3|                       0.6|NS           |            0.5|                             0.9|0.002              |          2.0|                           3.8|<0.001           |
|Cardiac disease            |Myocardial infarction                     |      0.0|                       0.0|NS           |            0.2|                             0.6|<0.001             |          0.4|                           0.9|<0.001           |
|Infection                  |Hospitalized infection                    |      0.1|                       0.2|NS           |            2.6|                             5.4|<0.001             |          7.1|                          12.7|<0.001           |
|Infection                  |Opportunistic infection                   |      0.9|                       0.5|NS           |            0.3|                             0.3|NS                 |          1.8|                           1.7|NS               |
|Inflammatory bowel disease |Crohn.s Disease                           |      4.6|                       2.6|<0.001       |            2.8|                             1.4|<0.001             |          3.6|                           2.3|<0.001           |
|Inflammatory bowel disease |Ulcerative Colitis                        |      2.5|                       1.3|0.006        |            1.5|                             0.8|<0.001             |          2.2|                           1.5|<0.001           |
|Lung disease               |Restrictive lung disease                  |      0.9|                       1.5|NS           |            0.6|                             0.9|0.017              |          5.3|                           7.8|<0.001           |
|Neurological Disease       |Spinal Cord compression                   |      0.1|                       0.3|NS           |            0.1|                             0.1|NS                 |          0.4|                           0.7|<0.001           |
|PsO/PsA                    |Psoriasis                                 |      3.4|                       1.5|<0.001       |            0.8|                             0.4|<0.001             |          2.5|                           1.1|<0.001           |
|Uveitis                    |Uveitis                                   |      4.4|                       3.9|NS           |            0.9|                             0.8|NS                 |          4.1|                           2.5|<0.001           |



|outcomeCategory            |disease                                   | MPCD TNF| MPCD DMARD|MPCD p-value | Marketscan TNF| Marketscan DMARD|Marketscan p-value | Medicare TNF| Medicare DMARD|Medicare p-value |
|:--------------------------|:-----------------------------------------|--------:|----------:|:------------|--------------:|----------------:|:------------------|------------:|--------------:|:----------------|
|Cancer                     |Hematologic Cancer                        |      0.2|        0.2|NS           |            0.2|              0.4|NS                 |          0.6|            1.3|<0.001           |
|Cancer                     |Non Melanoma Skin Cancer                  |      0.0|        0.0|NS           |            0.3|              0.3|NS                 |          1.0|            1.3|0.037            |
|Cancer                     |Solid Cancer                              |      1.8|        1.9|NS           |            0.9|              2.7|<0.001             |          4.0|            6.5|<0.001           |
|Cardiac disease            |Aortic Insufficiency/Aortic Regurgitation |      1.3|        0.5|NS           |            0.6|              0.5|NS                 |          1.9|            2.5|0.003            |
|Cardiac disease            |Conduction Block                          |      0.3|        0.0|NS           |            0.5|              0.5|NS                 |          2.0|            2.6|0.004            |
|Cardiac disease            |Myocardial infarction                     |      0.0|        0.0|NS           |            0.2|              0.2|NS                 |          0.4|            0.7|0.002            |
|Infection                  |Hospitalized infection                    |      0.1|        0.0|NS           |            2.6|              3.3|NS                 |          7.1|            9.2|<0.001           |
|Infection                  |Opportunistic infection                   |      0.9|        1.2|NS           |            0.3|              0.7|0.044              |          1.8|            2.1|NS               |
|Inflammatory bowel disease |Crohn.s Disease                           |      4.6|        3.1|NS           |            2.8|              2.4|NS                 |          3.6|            3.4|NS               |
|Inflammatory bowel disease |Ulcerative Colitis                        |      2.5|        0.7|0.018        |            1.5|              1.4|NS                 |          2.2|            2.2|NS               |
|Lung disease               |Restrictive lung disease                  |      0.9|        0.0|0.029        |            0.6|              0.6|NS                 |          5.3|            6.9|<0.001           |
|Neurological Disease       |Spinal Cord compression                   |      0.1|        0.0|NS           |            0.1|              0.2|NS                 |          0.4|            0.4|NS               |
|PsO/PsA                    |Psoriasis                                 |      3.4|        1.0|0.005        |            0.8|              0.6|NS                 |          2.5|            2.0|0.011            |
|Uveitis                    |Uveitis                                   |      4.4|        5.2|NS           |            0.9|              1.2|NS                 |          4.1|            3.1|<0.001           |
